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entire technical background of the electronic prescription reduces the risk of complications. 
When prescribing drugs, psychotropes and precursors, medicines under control, the patient 
receives the paper recipe in the Republic of Moldova and is written in 3 copies, in Romania - are 
4 copies, using 2 types of prescription: the yellow color when prescribing the medicines of Table 
2 and green - in Table 3 (Annex to Law 339/2005 RO). In Moldova the circulation of these drugs 
is regulated by the Law 382 of 06.05.1999, the Government Decision no.1088 of 05.10.2004 and 
the Order of the Ministry of Health no. 960 of 01.10.2012. 
Conclusions. In the Republic of Moldova, the number of OTC drugs is lower than in Romania, 
but in relation to the total number of those authorized, then in Romania 1 out of 17 authorized is 
OTC, and in Moldova 1 out of 3.5. The use of electronic prescriptions in the medication process 
minimizes medication errors caused by prescription and release of drugs. 
Key words: drugs prescriptions, pharmacy, OTC medicines 
 
373. BENEFICIAL EFFECTS AND SIDE EFFECTS CAUSED BY ISOFLAVONES 
FROM FOOD SUPPLEMENTS AND DERMATOCOSMETIC CREAMS  
 
Authors: Radu Uncu, Angelica Bat  
Scientific adviser: Donici Elena, University Assistant, Department of Pharmaceutical and 
Toxicological Chemistry 
Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova 
 
Introduction. Isoflavones are bioactive substances, also called phytoestrogens, because their 
chemical structure is similar to that of the human estradiol hormone. Significant amounts are 
found in soy and red clover in glycosidic form: genistin, daidzein and glycitin. The main users of 
isoflavone products are menopausal women seeking an alternative to hormone therapy. 
Currently, there are an enormous number of dietary supplements and cosmetic creams with 
isoflavones. Advertising and prospectuses assure consumers that products are natural, safe, 
although neither their benefit nor their safety has been sufficiently demonstrated.  
Aim of the study. Advanced bibliographic study on researches of the safety and risk-benefit 
ratio of isoflavones in food supplements and dermatocosmetic creams.  
Materials and methods. 116 abstracts and articles from systematic research in the Cochrane 
Electronic Library, MEDLINE databases, CAB Abstracts © CAB, and SciSearch © The 
Thomson Corporation.  
Results. Possible long-term carcinogenic effects and goitrogenic effects, by the thyroid 
inactivation of peroxidase by certain genistein concentrations (24% of the evaluated sources), 
have been identified. There are studies (21%) on adverse effects in fertility and reproductive tract 
toxicity in women. Experiments on mice after ovariectomy and implantation of breast cancer 
cells indicate stimulation of mammary tumor growth (5% of summaries). Several studies reveal 
an increased allergenic potential of isoflavones (9%). A large number of studies (27%) showed 
that genistein causes adverse effects on the female reproductive system, but also the involvement 
of isoflavones on central immune and central nervous systems (14%). However, a significant 
number of abstracts and articles can also be found, which also show beneficial effects in the 
improvement of vasomotor symptoms in the menopause.  
Conclusions. It has been found that data on the increased impact of isoflavones on menopausal 
problems of women are not enough and convincing, and long-term intake of high doses of 
isoflavone supplements for them is very risky. 
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Introduction. According of American Psychiatric Association,mental health is defined by the 
simultaneous success in work, love and the ability to resolve with maturity and flexibility the 
conflict between instinct, consciousness, close persons and reality.There is no universal 
definition.However, neuropsychiatric disorders are the third cause of disability in Europe and 
represent 15.2%, after cardiovascular disease 26.6% and malignant neoplasms (cancers) 
15.4%.The most common mental illnesses are anxiety, depression and dementia.It is estimated 
that by 2020 depression will become the second leading cause of disability worldwide, after 
cardiovascular diseases.  
Aim of the study. In this study we have proposed as the objective the recipe of the medical 
scientific literature of the contemporary therapy of depressive states.  
Materials and methods. The bibliographic and informative sources published in recent years, 
published both internationally and in the Republic of Moldova, have been used as study 
materials.  
Results. Scientific dates demonstrate that treatment of depressive states includes several groups 
of preparations: selective serotonin reuptake inhibitors (SSRIs),noradrenaline and dopamine 
reuptake inhibitors (IRND),selective serotonin reuptake enhancers (SSRIs),noradrenergic and 
serotoninergic antidepressants,serotonin and noradrenaline reuptake inhibitors (IRSN), 
monoamine oxidase inhibitors (MAOIs),tranquilizing benzodiazepines and non-
benzodiazepine.Of the classes of organic substances with MAO inhibitors are involved and 
derivatives of 2-indolinone and 2,3-indolinedione.In this context, a new autohtone compound of 
the isatine group is investigated, with pronounced antidepressant and sedative-tranquilizing 
activity–1'-(2-oxo-propyl)-spiro[[1,3]dioxolane-2',3'-indolin]-2'-one with the common name 
"DIOXOINDOLINONE" synthesized in the Organic Synthesis and Biopharma- ceutical 
Laboratory of the Institute of Chemistry.  
Conclusions. Although there are already a large number of antidepressant drugs in the 
pharmaceutical market, the development of new structures remains in the topicality.  
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Introduction. There are several options for monitoring ototoxic changes. Many ototoxicity 
monitoring protocols are based on the ototoxic profile of platinum in chemotherapy (eg cisplatin) 
and aminoglycoside antibiotics (Gentamycin, Tobramycin, Kanamycin, Streptomycin, etc.) 
because they are widely used and have a relatively high incidence in the ototoxic events. 
However, other ototoxins such as difluoromethylnitrine, loop diuretics and salicylates can cause 
a wide variety of other audiometric configurations. Therefore, for a drug with a poorly defined 
ototoxic or ototoxic profile, It is very important to monitor the ototoxicity of the drugs whether 
or not they cause hearing loss and cause changes that have met the criteria for adverse effects. 
